News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Anti-TNF Exposure Does Not Rule out TNF Inhibitor for Psoriasis, J. W. Goethe University Study


10/14/2009 10:58:59 AM

Bookmark and Share

MedPage Today -- BALTIMORE -- Eslicarbazepine acetate (Stedesa), a European anti-epileptic drug not yet licensed in the U.S., reduced seizure frequency and was well tolerated as an add-on treatment in patients with refractory partial-onset seizures in a trial reported here.

Read at MedPageToday

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES